Forbes: Oral Covid Vaccine Set To Begin Trials In Israel

Forbes discusses how Israel is gearing up to host the first clinical trials of Oravax’s oral Covid-19 vaccine, which could help boost access to vaccines around the world. The vaccine should be “much more resistant to Covid-19 variants,” Kidron said, as it trains the immune system against three viral proteins. Read more here.

You may also be interested

Join our mailing list

Skip to content